Cargando…
Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody
Rabies infection is nearly 100% lethal if untreated and kills more than 50,000 people annually, many of them children. Existing rabies vaccines target the rabies virus glycoprotein (RABV-G) but generate short-lived immune responses, likely because the protein is heterogeneous under physiological con...
Autores principales: | Callaway, Heather M., Zyla, Dawid, Larrous, Florence, de Melo, Guilherme Dias, Hastie, Kathryn M., Avalos, Ruben Diaz, Agarwal, Alyssa, Corti, Davide, Bourhy, Hervé, Saphire, Erica Ollmann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205594/ https://www.ncbi.nlm.nih.gov/pubmed/35714192 http://dx.doi.org/10.1126/sciadv.abp9151 |
Ejemplares similares
-
Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein
por: Hellert, Jan, et al.
Publicado: (2020) -
Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV
por: Hastie, Kathryn M., et al.
Publicado: (2016) -
Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein
por: Harshbarger, Wayne, et al.
Publicado: (2021) -
Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers
por: Rutten, Lucy, et al.
Publicado: (2020) -
The shift in rabies epidemiology in France: time to adjust rabies post-exposure risk assessment
por: Parize, Perrine, et al.
Publicado: (2018)